Cancer stem cells, self-seeding, and decremented exponential growth: Theoretical and clinical implications

Breast Disease

Volumn 29, Issue , 2007, Pages 27-36

  Norton, Larry ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIMITOTIC AGENT; ANTINEOPLASTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TAXANE DERIVATIVE;

ADJUVANT THERAPY; ANAPLASTIC CARCINOMA; ANGIOGENESIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER STEM CELL; CELL TYPE; DRUG MECHANISM; DRUG TREATMENT FAILURE; DYSPLASIA; GROWTH RATE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL MODEL; METASTASIS; PRIORITY JOURNAL; THEORY-PRACTICE RELATIONSHIP; TUMOR GROWTH; TUMOR VOLUME;

EID: 57049103357     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/bd-2008-29104     Document Type: Article

References (50)

1. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison and M.F. Clarke, Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci USA 100(7) (1 Apr 2003), 3983-3988.
2. A.W. Hamburger and S.E. Salmon, Primary bioassay of human tumor stem cells, Science 197(4302) (Jul 1977), 461-463.
3. I.J. Fidler and I.R. Hart, Biological diversity in metastatic neoplasms: origins and implications, Science 217(4564) (10 Sep 1982), 998-1003.
4. G.H. Heppner, Tumor heterogeneity, Cancer Res 44(6) (Jun 1984), 259-2265.
5. L.M. Weisenthal and M.E. Lippman, Clonogenic and non-clonogenic in vitro chemosensitivity assays, Cancer Treat Rep 69(6) (Jun 1985), 615-632.
6. M. Shackleton, F. Vaillant, K.J. Simpson, J. Stingl, G.K. Smyth, M.L. Asselin-Labat, L. Wu, G.J. Lindeman and J.E. Visvader, Generation of a functional mammary gland from a single stem cell, Nature 439 7072) (Jan 2006), 84-88.
7. A. Spradling, D. Drummond-Barbosa and T. Kai, Stem cells find their niche, Nature 414(6859) (1 Nov 2001), 98-104.
8. G.H. Smith, Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands, Development 132(4) (Feb 2005), 681-687.
9. C.S. Potten and M. Loeffler, Stem cells: Attributes, cycles, spirals, pitfalls and uncertainties, Lessons for and from the crypt, Development 110(4) (Dec 1990), 001-1020.
10. M.F. Clarke and M. Fuller, Stem cells and cancer: Two faces of eve, Cell 124(6) (24 Mar 2006), 1111-1115.
11. M. Cariati and A.D. Purushotham, Stem cells and breast cancer, Histopathology 52(1) (Jan 2008), 99-107.
12. J. Yang, S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson and R.A. Weinberg, Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis, Cell 117(7) (25 Jun 2004), 927-939.
13. T. Brabletz, F. Hlubek, S. Spaderna, O. Schmalhofer, E. Hiendlmeyer, A. Jung and T. Kirchner, Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin, Cells Tissues Organs 179(1-2) (2005), 56-65.
14. D.J. Nolan, A. Ciarrocchi, A.S. Mellick, J.S. Jaggi, K. Bambino, S. Gupta, E. Heikamp, M.R. McDevitt, D.A. Scheinberg, R. Benezra and V. Mittal, Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization, Genes Dev 21 12) (15 Jun 2007), 1546-1558.
15. M. Seandel, J. Butler, D. Lyden and S. Rafii, A catalytic role for proangiogenic marrow-derived cells in tumor neovascularization, Cancer Cell 13(3) (Mar 2008), 181-183.
16. V. Gocheva and J.A. Joyce, Cysteine cathepsins and the cutting edge of cancer invasion, Cell Cycle 6(1) (1 Jan 2007), 60-64.
17. A.E. Karnoub, A.B. Dash, A.P. Vo, A. Sullivan, M.W. Brooks, G.W. Bell, A.L. Richardson, K. Polyak, R. Tubo and R.A. Weinberg, Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature 449(7162) (4 Oct 2007), 557-563.
18. T. Reya and S.J. Morrison, M.F. Clarke, I.L. Weissman, Stem cells, cancer, and cancer stem cells, Nature 414(6859) (1 Nov 2001), 105-111.
19. L.A. Doyle, W. Yang, L.V. Abruzzo, T. Krogmann, Y. Gao, A.K. Rishi and D.D. Ross, A multidrug resistance transporter from human MCF-7 breast cancer cells, Proc Natl Acad Sci USA 95(26) (22 Dec 1998), 15665-15670.
20. R. Pardal, M.F. Clarke and S.J. Morrison, Applying the principles of stem-cell biology to cancer, Nat Rev Cancer 3(12) (Dec 2003), 895-902.
21. T.R. Golub, Genome-wide views of cancer, N Engl J Med 344(8) (22 Feb 2001), 601-602.
22. M. Al-Hajj, M.W. Becker, M. Wicha, I. Weissman and M.F. Clarke, Therapeutic implications of cancer stem cells, Curr Opin Genet Dev 14(1) (Feb 2004), 43-47.
23. H. Clayton, I. Titley and M. Vivanco, Growth and differentiation of progenitor/stem cells derived from the human mammary gland, Exp Cell Res 297(2) (15 Jul 2004), 444-460.
24. M. Cariati, A. Naderi, J.P. Brown, M.J. Smalley, S.E. Pinder, C. Caldas and A.D. Purushotham, Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line, Int J Cancer 122(2) (15 Jan 2008), 298-304.
25. A.M. Gonzalez-Angulo, F. Morales-Vasquez and G.N. Hortobagyi, Overview of resistance to systemic therapy in patients with breast cancer, Adv Exp Med Biol 608 (2007), 1-22.
26. L. Norton, R. Simon, H.D. Brereton and A.E. Bogden, Predicting the course of Gompertzian growth, Nature 264(5586) (9 Dec 1976 , 542-545.
27. L.A. Norton, Gompertzian model of human breast cancer growth, Cancer Res 48(24 Pt 1) (15 Dec 1988), 7067-7071.
28. L. Norton, Conceptual and practical implications of breast tissue geometry: Toward a more effective, less toxic therapy, Oncologist 10(6) (Jun-Jul 2005), 370-381.
29. Benjamin Gompertz. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies, Philosophical Transactions of the Royal Society of London 115 (Jun 1825), 513-583.
30. A.K. Laird and A.D. Barton, Cell growth and the development of tumours, Nature 183(4676) (13 Jun 1959), 1655-1657.
31. W.A. Woodward, M.S. Chen, F. Behbod and J.M. Rosen, On mammary stem cells, J Cell Sci 118(Pt 116) (15 Aug 2005), 3585-3594.
32. G. Dontu, D. El-Ashry and M.S. Wicha, Breast cancer, stem/progenitor cells and the estrogen receptor, Trends Endocrinol Metab 15 5) (Jul 2004), 193-197.
33. A.H. Sims, A. Howell, S.J. Howell and R.B. Clarke, Origins of breast cancer subtypes and therapeutic implications, Nat Clin Pract Oncol 4(9) (Sep 2007), 516-525.
34. L. Norton and J. Massagué, Is cancer a disease of self-seeding? Nat Med 12(8) (Aug 2006), 875-878.
35. A.J. Trimboli, K. Fukino, A. de Bruin, G. Wei, L. Shen, S.M. Tanner, N. Creasap, T.J. Rosol, M.L. Robinson, C. Eng, M.C. Ostrowski and G. Leone, Direct evidence for epithelial-mesenchymal transitions in breast cancer, Cancer Res 68(3) (1 Feb 2008), 937-945.
36. A.J. Minn, G.P. Gupta, P.M. Siegel, P.D. Bos, W. Shu, D.D. Giri, A. Viale, A.B. Olshen, W.L. Gerald and J. Massagué, Genes that mediate breast cancer metastasis to lung, Nature 436(7050) (28 Jul 2005), 518-524.
37. A.J. Minn, G.P. Gupta, D. Padua, P. Bos, D.X. Nguyen, D. Nuyten, B. Kreike, Y. Zhang, Y. Wang, H. Ishwaran, J.A. Foekens, M. van de Vijver and J. Massagué, Lung metastasis genes couple breast tumor size and metastatic spread, Proc Natl Acad Sci USA 104(16) (17 Apr 2007), 6740-6745.
38. R. Holland, S.H. Veling, M. Mravunac and J.H. Hendriks, Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery, Cancer 56(5) (1 Sep 1985), 979-990.
39. G.F. Schwartz, U. Veronesi, K.B. Clough, J.M. Dixon, I.S. Fentiman, S.H. Heywang-Köbrunner, R. Holland, K.S. Hughes, R.E. Mansel, R. Margolese, E.B. Mendelson, I.A. Olivotto, J.P. Palazzo and L.J. Solin, Consensus Conference Committee. Consensus conference on breast conservation, J Am Coll Surg 203(2) (Aug 2006), 198-207.
40. C. Ginestier and M.S. Wicha, Mammary stem cell number as a determinate of breast cancer risk, Breast Cancer Res 9(4) (2007), 109.
41. H.M. Hastings, B.S. Schneider, M.A. Schreiber, K. Gorray, G. Maytal and J. Maimon, Statistical geometry of pancreatic islets, Proc Biol Sci 250(1329) (22 Dec 1992), 257-261.
42. H. Korkaya and M.S. Wicha, Selective targeting of cancer stem cells: A new concept in cancer therapeutics, BioDrugs 21(5) (2007), 299-310.
43. D.F. Hayes, K. Miller and G. Sledge, Angiogenesis as targeted breast cancer therapy, Breast 2(Suppl) (16 Dec 2007), S17-S19.
44. A. Agrawal and I.S. Fentiman, NSAIDs and breast cancer: A possible prevention and treatment strategy, Int J Clin Pract 62(3) (Mar 2008), 444-449.
45. H.L. McArthur and C.A. Hudis, Advances in adjuvant chemotherapy of early stage breast cancer, Cancer Treat Res 141 (2008), 37-53.
46. G.N. Hortobagyi, Recent progress in the clinical development of docetaxel (Taxotere), Semin Oncol 26(3 suppl 9) (Jun 1999), 32-36.
47. T.A. Traina et al., JCO 2008.
48. F. Li, B. Tiede, J. Massagué and Y. Kang, Beyond tumorigenesis: cancer stem cells in metastasis, Cell Res 17(1) (Jan 2007), 3-14.
49. G. Farnie and R.B. Clarke, Mammary stem cells and breast cancer-role of Notch signalling, Stem Cell Rev 3(2) (Jun 2007), 169-175.
50. B.M. Boman, M.S. Wicha, J.Z. Fields and O.A. Runquist, Symmetric division of cancer stem cells-a key mechanism in tumor growth that should be targeted in future therapeutic approaches, Clin Pharmacol Ther 81(6) (Jun 2007), 893-898.